Mikhail Dvorkin

11.2k citations
43 papers · 924 indexed · 1 hit paper · h-index 13
Topics
Lung Cancer Research Studies (13 papers)Lung Cancer Treatments and Mutations (10 papers)Biosimilars and Bioanalytical Methods (9 papers)
Journals
The LancetJournal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations
United StatesRussiaItaly

In The Last Decade

Mikhail Dvorkin

42 papers receiving 906 citations

Hit Papers

Fulvestrant 500 mg versus anastrozole 1 mg for hormone re...20162026201920222016100200300

Peers

Mikhail Dvorkin
Comparison fields: 5 of 60
  • Oncology 746
  • Pulmonary and Respiratory Medicine 487
  • Cancer Research 211
  • Immunology 153
  • Epidemiology 137
Replace Zishuo I. Hu with:
Zishuo I. Hu United States
Marie Alt France
Sabrina Rossi Italy
Matthew D. Callister United States
W. Li China
Yuezong Bai China
Hidenobu Ishii Japan
Yasir Y. Elamin United States
Daniel Rauch Switzerland
Maria Chiara Tronconi Italy
Mikhail Dvorkin relative to Zishuo I. Hu United States Zishuo I. Hu's profile →
Citations per field
00.5×2.6×
Zishuo I. Hu · 1×
Citations per year

Countries citing papers authored by Mikhail Dvorkin

Since Specialization
Citations

This map shows the geographic impact of Mikhail Dvorkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail Dvorkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail Dvorkin more than expected).

Fields of papers citing papers by Mikhail Dvorkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikhail Dvorkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail Dvorkin. The network helps show where Mikhail Dvorkin may publish in the future.

Co-authorship network of co-authors of Mikhail Dvorkin

This figure shows the co-authorship network connecting the top 25 collaborators of Mikhail Dvorkin. A scholar is included among the top collaborators of Mikhail Dvorkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikhail Dvorkin. Mikhail Dvorkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 6
3 2
4 0
5 7
6 1
7 22
8 1
9 6
10 12
11 30
12 36
13 4
14 1
15 53
16 6
17 2
18 14
19 10
20
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trialbreakdown →
384

About Mikhail Dvorkin

Mikhail Dvorkin is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 43 papers that have together received 924 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (13 papers), Lung Cancer Treatments and Mutations (10 papers) and Biosimilars and Bioanalytical Methods (9 papers). The work is most often cited by research in Oncology (746 citations), Pulmonary and Respiratory Medicine (487 citations) and Cancer Research (211 citations). Mikhail Dvorkin has collaborated with scholars based in United States, Russia and Italy. Frequent co-authors include Igor Bondarenko, Yaroslav Shparyk, Ekaterina Trishkina, Alexey Manikhas, Matthew J. Ellis, Shinzaburo Noguchi, Servando Cardona‐Huerta, Lynda Grinsted, Kwok‐Leung Cheung and Lawrence Panasci. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026